| 1 |
Jiao FY, Mu ZL, DU ZD, Yang XD, Shen J, Xiang W, Wang H. [Diagnosis and treatment of incomplete Kawasaki disease in children]. Zhongguo Dang Dai Er Ke Za Zhi 2023;25:238-43. [PMID: 36946156 DOI: 10.7499/j.issn.1008-8830.2209127] [Reference Citation Analysis]
|
| 2 |
Haslak F, Gunalp A, Kasapcopur O. A cursed goodbye kiss from severe acute respiratory syndrome-coronavirus-2 to its pediatric hosts: multisystem inflammatory syndrome in children. Curr Opin Rheumatol 2023;35:6-16. [PMID: 36094472 DOI: 10.1097/BOR.0000000000000910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Zhang HY, Xiao M, Zhou D, Yan F, Zhang Y. Platelet and ferritin as early predictive factors for the development of macrophage activation syndrome in children with Kawasaki disease: A retrospective case-control study. Front Pediatr 2023;11:1088525. [PMID: 36873655 DOI: 10.3389/fped.2023.1088525] [Reference Citation Analysis]
|
| 4 |
Alexandri M, Patel J, Paul E, Coule LW. First report of a patient meeting criteria for both multisystem inflammatory syndrome in children and adult onset Still's disease. BMC Rheumatol 2022;6:87. [PMID: 36575537 DOI: 10.1186/s41927-022-00320-9] [Reference Citation Analysis]
|
| 5 |
Sobh A, Madiha Abdalla, Abdelrahman AM, Mosa DM. COVID-19 diversity: A case of multisystem inflammatory syndrome in children masquerading as juvenile systemic lupus erythematosus. Int J Immunopathol Pharmacol 2022;36:3946320221131981. [PMID: 36203358 DOI: 10.1177/03946320221131981] [Reference Citation Analysis]
|
| 6 |
Song S. Short-term Outcomes of Corticosteroid Monotherapy in COVID-19-Associated Multisystem Inflammatory Syndrome in Children-Handle With Caution. JAMA Pediatr 2022;176:945-6. [PMID: 35816340 DOI: 10.1001/jamapediatrics.2022.2325] [Reference Citation Analysis]
|
| 7 |
Tsoukas P, Yeung RSM. Kawasaki disease and MIS-C share a host immune response. Nat Rev Rheumatol 2022. [PMID: 36008614 DOI: 10.1038/s41584-022-00820-5] [Reference Citation Analysis]
|
| 8 |
Hosseini P, Fallahi MS, Erabi G, Pakdin M, Zarezadeh SM, Faridzadeh A, Entezari S, Ansari A, Poudineh M, Deravi N. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities. Front Mol Biosci 2022;9:804109. [DOI: 10.3389/fmolb.2022.804109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Kostik MM, Bregel LV, Avrusin IS, Efremova OS, Belozerov KE, Dondurei EA, Kornishina TL, Isupova EA, Abramova NN, Felker EY, Masalova VV, Santimov AV, Kozlov YA, Barakin AO, Snegireva LS, Konstantinova J, Vilnits AA, Bekhtereva MK, Argunova VM, Matyunova AE, Sleptsova PA, Burtseva TE, Shprakh VV, Boyko TV, Kalashnikova OV, Chasnyk VG. Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data. Front Pediatr 2022;10:829420. [PMID: 35311051 DOI: 10.3389/fped.2022.829420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Reiff DD, Cron RQ. Who Would Have Predicted Multisystem Inflammatory Syndrome in Children? Curr Rheumatol Rep 2022;24:1-11. [PMID: 35150412 DOI: 10.1007/s11926-022-01056-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 11 |
Buda P, Strauss E, Januszkiewicz-Lewandowska D, Czerwinska E, Ludwikowska K, Szenborn L, Gowin E, Okarska-Napierała M, Kuchar E, Ksia Zyk J. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome. Front Pediatr 2022;10:981711. [PMID: 36186637 DOI: 10.3389/fped.2022.981711] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Yamaguchi Y, Takasawa K, Irabu H, Hiratoko K, Ichigi Y, Hirata K, Tamura Y, Murakoshi M, Yamashita M, Nakatani H, Shimoda M, Ishii T, Udagawa T, Shimizu M, Kanegane H, Morio T. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Cells 2021;10:3592. [PMID: 34944099 DOI: 10.3390/cells10123592] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 14 |
Bagri NK, Deepak RK, Meena S, Gupta SK, Prakash S, Setlur K, Satapathy J, Chopra K, Upadhyay AD, Ramakrishnan S, Lodha R, Dar L, Trikha A, Kabra SK. Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study. Rheumatol Int 2021. [PMID: 34665296 DOI: 10.1007/s00296-021-05030-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 15 |
Kostik MM, Bregel LV, Avrusin IS, Dondurei EA, Matyunova AE, Efremova OS, Isupova EA, Kornishina TL, Masalova VV, Snegireva LS, Shprakh VV, Kozlov YA, Kalashnikova OV, Chasnyk VG. Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study. Front Pediatr 2021;9:787353. [PMID: 34858909 DOI: 10.3389/fped.2021.787353] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 16 |
Generalić A, Davidović M, Kos I, Vrljičak K, Lamot L. Hematuria as an Early Sign of Multisystem Inflammatory Syndrome in Children: A Case Report of a Boy With Multiple Comorbidities and Review of Literature. Front Pediatr 2021;9:760070. [PMID: 34778150 DOI: 10.3389/fped.2021.760070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
